Computerised System Access Controls: Roles and Periodic Review explains how pharmaceutical quality teams can implement EU GMP Annex 11 controls to protect patient safety, data reliability and inspection readiness. The following is educational guidance, not a substitute for a site-approved procedure.

Regulatory expectations and scope
Data integrity is a lifecycle responsibility spanning record creation, processing, review, retention, retrieval and disposal. Controls should reflect the criticality of the data, system complexity, authorised workflows and the risk of undetected manipulation or accidental loss. MHRA GxP Data Integrity Guidance and EU GMP Annex 11 provide useful regulatory context; applicability depends on the system and jurisdiction.
Practical implementation steps
- Map the data flow: identify original records, metadata, processing steps, interfaces, archives and authorised users.
- Assess risk: identify which activities could change critical results without adequate detection.
- Implement controls: Use individual accounts, least privilege, approved access requests, periodic reviews and prompt deactivation.
- Test the controls: challenge representative normal, incorrect and unauthorised actions and document evidence.
- Review and maintain: investigate exceptions, train users, monitor changes and reassess after software or workflow modifications.
Realistic QC laboratory example
An analyst should not have unrestricted administrator rights that permit alteration of approved methods or deletion of audit logs. A quality review should establish the reason for the event, whether original data remain intact, the potential effect on reported results and whether corrective action is needed.
Common inspection gaps
- Shared accounts prevent reliable attribution.
- Static printouts are treated as complete originals when dynamic data and metadata are essential.
- Audit trails are enabled but not reviewed for critical events.
- Spreadsheet formulas are changed without version control or testing.
- Backups exist but restoration and long-term retrieval have not been demonstrated.
QA review checklist
- Is intended system use documented and validated where required?
- Are accounts unique and access privileges justified?
- Are raw data, metadata and audit trails complete and retrievable?
- Are changes attributable and scientifically justified?
- Are critical records independently reviewed before quality decisions?
- Are backup, recovery, retention and periodic review documented?
Frequently asked questions
Is a PDF export sufficient for data integrity?
Not necessarily. Where dynamic electronic records, metadata or audit trails are needed to reconstruct an activity, a static PDF may be insufficient as the sole retained record.
How often should controls be reviewed?
Frequency should be documented and risk-based, considering record criticality, system functionality, change frequency and historical issues rather than using an unsupported universal interval.
Official references
MHRA GxP Data Integrity Guidance and EU GMP Volume 4, Annex 11. Consult current versions and applicable local requirements.


